Your session is about to expire
← Back to Search
Emtricitabine/Stavudine + Didanosine/Efavirenz for HIV Infection
Study Summary
This trial will compare the safety and effectiveness of three different HIV medications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I cannot eat one or more meals a day due to ongoing symptoms.I am 18 years old or older.My HIV viral load is 5,000 copies/ml or higher.I am currently receiving treatment for active tuberculosis.I am not taking medications like astemizole, cisapride, or St. John's wort.I have or had nerve damage in my hands or feet.I can be contacted by phone.I have not used HIV medication for more than 2 days.I am 18 years old or older.I have not taken HIV medication for more than 2 days.I am willing to use effective birth control during the study.I have had certain serious infections or cancers in the past.I cannot take medicine by mouth or have had severe diarrhea recently.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you explain the age restrictions for this research project?
"The age requirement to enroll in this trial is 18 to 0 years old. There are a total of 109 studies for patients under 18 and 364 for those over 65."
How many staff members are needed to manage this clinical trial at each location?
"This trial has a presence in George Washington Univ Med Ctr in Washington, District of Columbia, Howard Grossman in New york, New York, Viridae Clinical Sciences / University of British Columbia in Vancouver, British Columbia, and 55 other medical centres."
Are there any patients currently enrolled in this research?
"No, the clinical trial is not recruiting patients at the moment. The clinical trial was originally posted on 8/1/2000 and was last updated on 6/23/2005. There are 495 other studies presently searching for participants right now."
What side effects should patients be made aware of before starting this medication regimen?
"This trial is a Phase 3, which suggests that while there is data affirming the treatment's efficacy, there are also multiple rounds of data supporting safety. Therefore, the safety of the treatment was rated a 3."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger